Biosensors and Nanotheranostics

Bionanotechnology, Drug Delivery, Therapeutics | online ISSN 3064-7789
175
Citations
127.7k
Views
108
Articles
Your new experience awaits. Try the new design now and help us make it even better
Switch to the new experience
REVIEWS   (Open Access)

Nanomedicine in Cancer Therapy: A  Review of Therapeutic Applications and Clinical Outcomes

Abstract 1. Introduction 2. Methods and Materials 3. Results 4. Discussion 6. Limitations of this study 7. Conclusion References

Loiy Elsir Ahmed Hassan 1*, Amin Malik Shah Abdul Majid 2,3

+ Author Affiliations

Biosensors and Nanotheranostics 4 (1) 1-8 https://doi.org/10.25163/biosensors.4110519

Submitted: 09 June 2025 Revised: 26 July 2025  Accepted: 04 August 2025  Published: 05 August 2025 


Abstract

Nanomedicine has emerged as a transformative approach in cancer therapy, offering innovative strategies to enhance drug delivery, diagnostic imaging, gene therapy, and immunotherapy. This systematic review and meta-analysis synthesize preclinical and clinical evidence from recent studies, highlighting the therapeutic efficacy, safety, and clinical translation of nanomaterials. Data from pivotal clinical trials, including CAR-T therapies (ZUMA-1, JULIET) and immune checkpoint inhibitor combinations (CheckMate-067, KEYNOTE-189), demonstrate significant improvements in overall response rates, complete remission, and survival outcomes compared to conventional treatments (Garg et al., 2024a, 2024b). Preclinical studies evaluating iron oxide nanoparticles, gold nanoparticles, and photosensitizer-loaded nanocarriers reveal enhanced tumor targeting, reduced systemic toxicity, and synergistic therapeutic effects when combined with photodynamic therapy or gene delivery approaches (Grancharova et al., 2024; Rehan et al., 2024). Meta-analytic assessment indicates that nanomedicine-based interventions consistently improve tumor-specific outcomes while maintaining manageable safety profiles across diverse cancer types. The integration of imaging and theranostic functionalities further enables precise monitoring of treatment response and tumor progression. Despite these promising results, translational challenges remain, including heterogeneity in nanoparticle design, variability in clinical response, and regulatory hurdles for clinical adoption. This review underscores the potential of nanomedicine to revolutionize oncology practice while emphasizing the need for standardized protocols and larger multicenter trials to validate efficacy. Overall, the evidence suggests that nanomedicine represents a critical advancement in personalized cancer therapy, combining therapeutic potency with diagnostic precision to optimize patient outcomes.

Keywords: Nanomedicine; Cancer Therapy; Nanoparticles; CAR-T Therapy; Immune Checkpoint Inhibitors; Photodynamic Therapy; Gene Delivery; Systematic Review; Meta-Analysis

References

Adir, O., Poley, M., Chen, G., From, S., Krinsky, N., Shklover, J., Roitman, J. S., Lammers, T., & Schroeder, A. (2020). Integrating artificial intelligence and nanotechnology for precision cancer medicine. Advanced Materials, 32, e1901989. https://doi.org/10.1002/adma.201901989

Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nature Biotechnology, 29(4), 341–345. https://doi.org/10.1038/nbt.1807

Basak, U., Sarkar, T., Mukherjee, S., Chakraborty, S., Dutta, A., Dutta, S., Nayak, D., Kaushik, S., Das, T., & Sa, G. (2023). Tumor-associated macrophages: An effective player of the tumor microenvironment. Frontiers in Immunology, 14, 1295257. https://doi.org/10.3389/fimmu.2023.1295257

Bezbaruah, R., Chavda, V. P., Nongrang, L., Alom, S., Deka, K., Kalita, T., Ali, F., Bhattacharjee, B., & Vora, L. (2022). Nanoparticle-based delivery systems for vaccines. Vaccines, 10, 1946. https://doi.org/10.3390/vaccines10111946

Byeon, J. H., & Park, J. H. (2016). Use of aerosol route to fabricate positively charged Au/Fe3O4 Janus nanoparticles as multifunctional nanoplatforms. Scientific Reports, 6, 35104. https://doi.org/10.1038/srep35104

Casadidio, C., Hartman, J. E. M., Mesquita, B. S., Haegebaert, R., Remaut, K., Neumann, M., Hak, J., Censi, R., Di Martino, P., & Hennink, W. E. (2023). Effect of polyplex size on penetration into tumor spheroids. Molecular Pharmaceutics, 20(11), 5515–5531. https://doi.org/10.1021/acs.molpharmaceut.3c00397

Chen, J., Guo, Z., Tian, H., & Chen, X. (2016). Production and clinical development of nanoparticles for gene delivery. Molecular Therapy Methods & Clinical Development, 3, 16023. https://doi.org/10.1038/mtm.2016.23

Chen, Q., Feng, L., Liu, J., Zhu, W., Dong, Z., Wu, Y., & Liu, Z. (2016). Intelligent albumin-MnO2 nanoparticles as pH-/H2O2-responsive dissociable nanocarriers to modulate tumor hypoxia for effective combination therapy. Advanced Materials, 28, 7129–7136. https://doi.org/10.1002/adma.201601902

Cross, R. (2021). Without these lipid shells, there would be no mRNA vaccines for COVID-19. Chemical & Engineering News, 99, 144.

Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010). Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature, 464(7291), 1067–1070. https://doi.org/10.1038/nature08956

Debele, T. A., Yeh, C. F., & Su, W. P. (2020). Cancer immunotherapy and application of nanoparticles in cancers immunotherapy as the delivery of immunotherapeutic agents and as the immunomodulators. Cancers, 12, 3773. https://doi.org/10.3390/cancers12123773

Duan, L., Ouyang, K., Xu, X., Xu, L., Wen, C., Zhou, X., Qin, Z., Xu, Z., Sun, W., & Liang, Y. (2021). Nanoparticle delivery of CRISPR/Cas9 for genome editing. Frontiers in Genetics, 12, 673286. https://doi.org/10.3389/fgene.2021.673286

Garg, P., Mohanty, A., Ramisetty, S., Kulkarni, P., Horne, D., Pisick, E., Salgia, R., & Singhal, S. S. (2023). Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers. Biochimica et Biophysica Acta Reviews on Cancer, 1878, 189026. https://doi.org/10.1016/j.bbcan.2023.189026

Garg, P., Pareek, S., Kulkarni, P., Horne, D., Salgia, R., & Singhal, S. S. (2024a). Next-generation immunotherapy: Advancing clinical applications in cancer treatment. Journal of Clinical Medicine, 13, 6537. https://doi.org/10.3390/jcm13216537

Garg, P., Pareek, S., Kulkarni, P., Salgia, R., & Singhal, S. S. (2024b). Nanoengineering solutions for cancer therapy: Bridging the gap between clinical practice and translational research. Journal of Clinical Medicine, 13, 3466. https://doi.org/10.3390/jcm13123466

Grancharova, T., Zagorchev, P., & Pilicheva, B. (2024). Iron oxide nanoparticles: Parameters for optimized photoconversion efficiency in synergistic cancer treatment. Journal of Functional Biomaterials, 15(8), 207. https://doi.org/10.3390/jfb15080207

Hasan, A., Morshed, M., Memic, A., Hassan, S., Webster, T. J., & Marei, H. E. (2018). Nanoparticles in tissue engineering: Applications, challenges and prospects. International Journal of Nanomedicine, 13, 5637–5655. https://doi.org/10.2147/IJN.S153758

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021). Lipid nanoparticles for mRNA delivery. Nature Reviews Materials, 6, 1078–1094. https://doi.org/10.1038/s41578-021-00358-0

Islam, R., Kotalik, K., Subr, V., Gao, S., Zhou, J. R., Yokomizo, K., Etrych, T., & Fang, J. (2023). HPMA copolymer conjugated 5-aminolevulinic acid exhibits superior efficacy for photodynamic therapy with tumor-responsive and targeting properties. Nanomedicine, 48, 102636. https://doi.org/10.1016/j.nano.2022.102636

Jin, L., Wang, Q., Chen, J., Wang, Z., Xin, H., & Zhang, D. (2019). Efficient delivery of therapeutic siRNA by Fe3O4 magnetic nanoparticles into oral cancer cells. Pharmaceutics, 11, 615. https://doi.org/10.3390/pharmaceutics11110615

Kiaie, S. H., Salehi-Shadkami, H., Sanaei, M. J., Azizi, M., Shokrollahi Barough, M., Nasr, M. S., & Sheibani, M. (2023). Nano-immunotherapy: Overcoming delivery challenge of immune checkpoint therapy. Journal of Nanobiotechnology, 21, 339. https://doi.org/10.1186/s12951-023-02083-y

Lakshmanan, V.-K., Jindal, S., Packirisamy, G., Ojha, S., Lian, S., Kaushik, A., Alzarooni, A. I. M. A., Metwally, Y. A. F., Thyagarajan, S. P., & Do Jung, Y. (2021). Nanomedicine-based cancer immunotherapy: Recent trends and future perspectives. Cancer Gene Therapy, 28, 911–923. https://doi.org/10.1038/s41417-021-00299-4

Li, T., Yang, Y., Qi, H., Cui, W., Zhang, L., Fu, X., He, X., Liu, M., Li, P.-f., & Yu, T. (2023). CRISPR/Cas9 therapeutics: Progress and prospects. Signal Transduction and Targeted Therapy, 8, 36. https://doi.org/10.1038/s41392-023-01309-7

Liu, Q., Zhao, K., Wang, C., Zhang, Z., Zheng, C., Zhao, Y., Zheng, Y., Liu, C., An, Y., & Shi, L. (2019). Multistage delivery nanoparticle facilitates efficient CRISPR/dCas9 activation and tumor growth suppression in vivo. Advanced Science, 6, 1801423. https://doi.org/10.1002/advs.201801423

Luo, H., & Gao, S. (2023). Recent advances in fluorescence imaging-guided photothermal therapy and photodynamic therapy for cancer: From near-infrared-I to near-infrared-II. Journal of Controlled Release, 362, 425–445. https://doi.org/10.1016/j.jconrel.2023.08.056

Maeda, H. (2015). Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Advanced Drug Delivery Reviews, 91, 3–6. https://doi.org/10.1016/j.addr.2015.01.002

Maeda, H., Nakamura, H., & Fang, J. (2013). The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Advanced Drug Delivery Reviews, 65, 71–79. https://doi.org/10.1016/j.addr.2012.10.002

McBain, S. C., Yiu, H. H., & Dobson, J. (2008). Magnetic nanoparticles for gene and drug delivery. International Journal of Nanomedicine, 3(2), 169–180. https://doi.org/10.2147/IJN.S1608

Mundekkad, D., & Cho, W. C. (2022). Nanoparticles in clinical translation for cancer therapy. International Journal of Molecular Sciences, 23, 1685. https://doi.org/10.3390/ijms23031685

Nawaz, W., Xu, S., Li, Y., Huang, B., Wu, X., & Wu, Z. (2020). Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy. Acta Biomaterialia, 109, 21–36. https://doi.org/10.1016/j.actbio.2020.04.015

Rehan, F., Zhang, M., Fang, J., & Greish, K. (2024). Therapeutic applications of nanomedicine: Recent developments and future perspectives. Molecules, 29, 2073. https://doi.org/10.3390/molecules29092073

Roma-Rodrigues, C., Rivas-García, L., Baptista, P. V., & Fernandes, A. R. (2020). Gene therapy in cancer treatment: Why go nano? Pharmaceutics, 12, 233. https://doi.org/10.3390/pharmaceutics12030233

Ryou, S.-M., Kim, J.-M., Yeom, J.-H., Hyun, S., Kim, S., Han, M. S., Kim, S. W., Bae, J., Rhee, S., & Lee, K. (2011). Gold nanoparticle-assisted delivery of small, highly structured RNA into the nuclei of human cells. Biochemical and Biophysical Research Communications, 416, 178–183. https://doi.org/10.1016/j.bbrc.2011.11.020

Stickdorn, J., Stein, L., Arnold-Schild, D., Hahlbrock, J., Medina-Montano, C., Bartneck, J., Ziß, T., Montermann, E., Kappel, C., & Hobernik, D. (2022). Systemically administered TLR7/8 agonist and antigen-conjugated nanogels govern immune responses against tumors. ACS Nano, 16, 4426–4443. https://doi.org/10.1021/acsnano.1c10709

Sun, D., Zhang, Z., Chen, M., Zhang, Y., Amagat, J., Kang, S., Zheng, Y., Hu, B., & Chen, M. (2020). Co-immobilization of Ce6 sono/photosensitizer and protonated graphitic carbon nitride on PCL/gelation fibrous scaffolds for combined sono-photodynamic cancer therapy. ACS Applied Materials & Interfaces, 12, 40728–40739. https://doi.org/10.1021/acsami.0c08446

Tsao, H.-Y., Cheng, H.-W., Kuo, C.-C., & Chen, S.-Y. (2022). Dual-sensitive gold-nanocubes platform with synergistic immunotherapy for inducing immune cycle using NIR-mediated PTT/NO/IDO. Pharmaceuticals, 15(2), 138. https://doi.org/10.3390/ph15020138

Wang, L., Wang, M., Zhou, B., Zhou, X., Zhang, X., & Fang, J. (2021). Photoacoustic and magnetic resonance imaging-based gene and photothermal therapy using mesoporous nanoagents. Bioactive Materials, 9, 157–167. https://doi.org/10.1016/j.bioactmat.2021.07.025

Wen, X., Shi, D., & Zhang, N. (2005). Applications of nanotechnology in tissue engineering. In T. S., Y. Grohens, & N. Ninan (Eds.), Handbook of nanostructured biomaterials and their applications in nanobiotechnology (Vol. 1, pp. 1–23). American Scientific Publishers.

Xu, X., Liu, C., Wang, Y., Koivisto, O., Zhou, J., Shu, Y., & Zhang, H. (2021). Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment. Advanced Drug Delivery Reviews, 176, 113891. https://doi.org/10.1016/j.addr.2021.113891

Yang, M., Li, J., Gu, P., & Fan, X. (2021). The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Bioactive Materials, 6, 1973–1987. https://doi.org/10.1016/j.bioactmat.2020.12.010

Zhang, J., Zhang, T., & Gao, J. (2022). Biocompatible iron oxide nanoparticles for targeted cancer gene therapy: A review. Nanomaterials, 12(19), 3323. https://doi.org/10.3390/nano12193323

Zhou, N., Zhang, C. T., Lv, H. Y., Hao, C. X., Li, T. J., Zhu, J. J., Zhu, H., Jiang, M., Liu, K. W., Hou, H. L., et al. (2019). Concordance study between IBM Watson for Oncology and clinical practice for patients with cancer in China. Oncology, 24, 812–819. https://doi.org/10.1634/theoncologist.2018-0255

Zhu, Y., Shen, R., Vuong, I., Reynolds, R. A., Shears, M. J., Yao, Z.-C., Hu, Y., Cho, W. J., Kong, J., Reddy, S. K., et al. (2022). Multi-step screening of DNA/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression. Nature Communications, 13, 4282. https://doi.org/10.1038/s41467-022-31993-y


Article metrics
View details
0
Downloads
0
Citations
16
Views

View Dimensions


View Plumx


View Altmetric



0
Save
0
Citation
16
View
0
Share